PURE Bioscience, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
PURE Bioscience, Inc. (PURE) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price of $0.88 per share for the 6-month period ending 2021-01-31, per its 10-Q filed 2021-03-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice · last filed 2021-03-15
- PURE Bioscience, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2020 was $0.82.
- PURE Bioscience, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2013 was $0.00.
- PURE Bioscience, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- PURE Bioscience, Inc. share-based compensation arrangements by share-based payment award, options, exercises in period, weighted average exercise price for fiscal 2011 was $5.11.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price 12 month |
|---|---|---|
| 2021-01-31 | $0.88 10-Q · filed 2021-03-15 | |
| 2020-07-31 | $0.82 10-K · filed 2020-10-08 | |
| 2013-07-31 | $0.00 10-K · filed 2013-10-24 | |
| 2012-07-31 | $0.00 10-K · filed 2013-10-24 | |
| 2011-07-31 | $5.11 10-K · filed 2012-10-29 |